Brief: Adaptive Biotechnologies Receives Expanded Medicare Coverage Of Clonoseq
28/07/2022 12:49
July 28 (Reuters) - Adaptive Biotechnologies Corp ADPT.O :
* ADAPTIVE BIOTECHNOLOGIES RECEIVES EXPANDED MEDICARE
COVERAGE OF
CLONOSEQ® FOR MONITORING MINIMAL RESIDUAL DISEASE IN DIFFUSE
LARGE B-CELL LYMPHOMA
Source text for Eikon: ID:nGNX6Jdym3
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates